Find your next paid study

Merck Sharp & Dohme LLCNCT07705607

Phase 3

A Randomized, Double-Masked, Multicenter, 3-Arm, Pivotal Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal (IVT) MK-8748 Compared With Aflibercept (2 mg) in Participants With Diabetic Macular Edema (DME)

Researchers are looking for new ways to treat diabetic macular edema (DME). In this trial, researchers want to learn if a trial medicine called MK-8748 can tre…

Diabetic RetinopathyMacular Edema

Merck Sharp & Dohme LLCNCT07705555

A Randomised, Double-masked, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Oral BI 1815368 in Participants With Centre-involved Diabetic Macular Edema for 48 Weeks of Treatment (THULITE)

This study is open to adults 18 and older with an eye condition called diabetic macular edema. People are required to have a specific type of diabetic macular …

Macular Edema

Boehringer IngelheimNCT06962839

~$10 – $7,500

Lactiplantibacillus Plantarum 299v Probiotic Probiotic Supplementation in Patients With Diabetic Macular Edema

This pilot prospective, interventional, longitudinal study, aims to evaluate the potential benefits of the probiotic supplement Lactobacillus plantarum 299v in…

Diabetic Macular Edema

Massachusetts Eye and Ear InfirmaryNCT07383701

~$10 – $7,500

Phase 1

A First-in-human, Open-label (Part 1), Randomized (Part 2), Phase I/IIa Trial to Study Safety and Tolerability of Multiple Rising Intravitreal Doses of BI 3812465 in Patients With Center-involved Diabetic Macular Edema

This study is open to adults with diabetic macular edema that involves the center of the eye. The purpose of this study is to find out how well different doses…

Diabetic Macular Edema

Boehringer IngelheimNCT07553429

~$10 – $7,500

Phase 4

Corticosteroid for Diabetic Macular Edema (DME) Study

Our current goals include confirming inflammation mediators are biomarkers of DR and DME The Aim of this project is to measure aqueous PGE2 and inflammatory c…

Diabetic Macular Edema (DME)Diabetic Retinopathy

Vanderbilt University Medical CenterNCT07843849

~$10 – $6,250

Phase 1

A Phase I, Multicenter, Open-Label, Multiple-Ascending Dose Study of the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 Administered by Intravitreal Injection as Monotherapy and in Combination With Faricimab in Patients With Diabetic Macular Edema

The purpose of this study is to evaluate the safety, tolerability, Pharmacodynamics (PD), and Pharmacokinetics (PK) of multiple doses of RO7823653 in participa…

Diabetic Macular Edema

Genentech, Inc.NCT07425522

Diabetic Macular Edema (DME)

A Randomized, Double-Masked, Multicenter Phase 2 Study Evaluating the Efficacy, Safety, and Tolerability of Oral BGE-102 as Mono- and Combination Therapy in Participants With Center-Involved Diabetic Macular Edema

The purpose of this study is to learn about the effects of BGE-102 on change in vision in participants with center-involved diabetic macular edema (CI-DME). BG…

BioAge Labs, Inc.NCT07812090

Phase 3

A Randomized, Double-masked, Active-controlled, Multi-center, Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal Tabirafusp Tedromer 5 mg Compared With Intravitreal Aflibercept 2 mg in Participants With Visual Impairment Secondary to Diabetic Macular Edema (DME) - ALTO

A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants with Diabetic Macular Edema - ALTO

Diabetic Macular Edema (DME)

Kodiak Sciences IncNCT07734844

Phase 1

A Phase 1 Study To Assess The Safety And Efficacy Of OCU200 For Center-Involved Diabetic Macular Edema

A Phase 1 study to assess the safety and efficacy of OCU200 for center-involved diabetic macular edema

Center Involved Diabetic Macular EdemaDiabetic Macular Edema

Addressing Low Patient Follow-up Rates Among Patients With Diabetes in the Eye Clinic at Zuckerberg San Francisco General Hospital and Trauma Center

The study will evaluate whether videos can improve understanding of diabetic eye disease, and follow-up rates in the eye clinic.

Diabetic Retinopathy (DR)Macular Edema (ME)

University of California, San FranciscoNCT07519707

~$10 – $5,625

Diabetic Macular Edema (DME)

Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Combining Tauroursodeoxycholate and Traditional Chinese Medicine.

Diabetic macular edema is seen in the later stages of diabetic retinopathy with current conventional therapies targeting local vascular dysfunction. These ther…